09 January 2002
NOC/oFQ activates PKC and generates superoxide to impair hypotensive cerebrovasodilation after hypoxia/ischemia.
William ArmsteadMed Sci Monit 2002; 8(1): BR :: ID: 420978
Abstract
BACKGROUND: Previous studies have observed that hypotensive pial arterydilation was blunted following global cerebral ischemia in the piglet. In unrelated studies, superoxide(O-2) contributed to impaired hypotensive cerebrovasodilation following traumatic brain injury in therat while the opioid nociceptin/orphanin FQ (NOC/oFQ) generated O-2 via activation of protein kinaseC in the piglet. This study determined the contribution of NOC/oFQ, PKC activation and O-2 generationin hypoxic ischemic hypotensive cerebrovasodilation impairment.Material/Methods: Anesthetized newbornpigs equipped with a closed cranial window were used. Global cerebral ischemia was produced via elevatedintracranial pressure. Hypoxia, via inhalation of nitrogen, decreased PO2 to 34I3 mmHg. RESULTS: TopicalNOC/oFQ (10-10M), the CSF concentration following hypoxia/ischemia, had no effect on pial artery diameterby itself but attenuated hypotension (mean arterial blood pressure decrease of 44I2%) induced pial arterydilation (33I1 vs 19I2%). Coadministration of the PKC inhibitor chelerythrine (10-7M) or the O-2 scavengerpolyethylene glycol superoxide dismutase and catalase (SODCAT) with NOC/oFQ (10-10M) partially preventedhypotensive pial dilation impairment (34I2 vs 28I1% for SODCAT). Hypotensive pial artery dilation wasblunted by hypoxia/ischemia but such dilation was partially protected by the NOC/oFQ receptor antagonist[F/G] NOC/oFQ (1-13) NH2 (10-6M), chelerythine or SODCAT (34I1 vs 7I2 vs 21I2% for sham, H/I and H/I+ SODCAT, respectively). CONCLUSIONS: These data show that PKC activation and generation of O-2 contributesto hypoxia/ischemia impairment of hypotensive pial artery dilation. These data suggest that NOC/oFQ activatesPKC and generates O-2 to impair hypotensive cerebrovasodilation after hypoxia/ischemia.
Keywords: Animals, Newborn, Anoxia, Arteries, Brain, Ischemia, Models, Biological, Opioid Peptides, Oxygen, Pressure, Protein Kinase C, Research Support, Non-U.S. Gov, Research Support, U.S. Gov, Superoxides, Swine, Time Factors, Vasodilation
Editorial
01 April 2024 : Editorial
Editorial: Forty Years of Waiting for Prevention and Cure of HIV Infection – Ongoing Challenges and Hopes for Vaccine Development and Overcoming Antiretroviral Drug ResistanceDOI: 10.12659/MSM.944600
Med Sci Monit 2024; 30:e944600
In Press
08 Mar 2024 : Clinical Research
Evaluation of Foot Structure in Preschool Children Based on Body MassMed Sci Monit In Press; DOI: 10.12659/MSM.943765
15 Apr 2024 : Laboratory Research
The Role of Copper-Induced M2 Macrophage Polarization in Protecting Cartilage Matrix in OsteoarthritisMed Sci Monit In Press; DOI: 10.12659/MSM.943738
07 Mar 2024 : Clinical Research
Knowledge of and Attitudes Toward Clinical Trials: A Questionnaire-Based Study of 179 Male Third- and Fourt...Med Sci Monit In Press; DOI: 10.12659/MSM.943468
08 Mar 2024 : Animal Research
Modification of Experimental Model of Necrotizing Enterocolitis (NEC) in Rat Pups by Single Exposure to Hyp...Med Sci Monit In Press; DOI: 10.12659/MSM.943443
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952